Explore cutting-edge advancements in cancer early detection through this informative 90-minute session moderated by Dr. Jesse Jokerst and Dr. Cristina Zaveleta. Gain insights from leading experts Dr. Norman Sharpless, Dr. Ralph Weissleder, Dr. David Suhy, and Sangeeta Bhatia as they discuss crucial topics including the National Cancer Institute's initiatives, early commercialization efforts, and the impact of the National Cancer Act. Delve into annual reports, the RAS Initiative, CPTAC, and various cancer screening methods. Learn about the intersection of coronavirus research and cancer detection, with a focus on lung cancer screening and emerging technologies. Discover how these advancements are shaping the future of cancer diagnosis and treatment, and understand the importance of ongoing research in this critical field.